Cantonbio
Chemicals & Related Products · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Chuangzhihui Industrial Park No. 19 Nanx...Phone Number
+86 2031800171Website
www.cantonbio.comRevenue
$6.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Cantonbio
Founded in 2016, Canton Biologics focuses on developing and manufacturing monoclonal antibodies, bispecific antibodies and other therapeutic recombinant proteins. The company's headquarters are located in Guangzhou, China, with a holding subsidiary in Switzerland and a CMO and an R&D unit in Foshan, China. With a protein drug production line that meets the FDA, EMA and the Chinese cGMP standards, Canton Biologics is building the most efficient biopharmaceutical R&D and production platform in South China. The company is built on principles of respect, openness and pragmatism. The management team consists of international experts and local experts with international experience. CantonBio employees are highly skilled, with nearly half having a master's degree or above. OUR CAPACITYExplore more
Popular SearchesCantonbio LtdCanton BiologicsCantonBioCantonBio AGSIC Code 28,283NAICS Code 32,325Show moreCantonbio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cantonbio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cantonbio had a recent Job posting/layoffs
Earning: See what the market has to say on Cantonbio recently announced quarterly report
Check out if Cantonbio is spiking on competitors!
Cantonbio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Cantonbio
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cantonbio launches new products
Check if Cantonbio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cantonbio has new funding data
Recommended Actions
Find VP level buyers at Cantonbio
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cantonbio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cantonbio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cantonbio.
Cantonbio financials insights
Gather financial insights about Cantonbio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series C
$41M
Cantonbio Tech Stack
A closer look at the technologies used by Cantonbio
Cantonbio News & Media
Read more news
Top Chemicals & Related Products Companies
See more top companies
Frequently Asked Questions Regarding Cantonbio
Sign Up For FreeTo access detailed company insights
Founded in 2016, Canton Biologics focuses on developing and manufacturing monoclonal antibodies, bispecific antibodies and other therapeutic recombinant proteins. The company's headquarters are located in Guangzhou, China, with a holding subsidiary in Switzerland and a CMO and an R&D unit in Foshan, China. With a protein drug production line that m... Read More
